Table 1. Different iVα14 NKT subsets in total lymphocytes of thymus, spleen and liver in WT, B7-1/2 and CD28 deficient mice.
WT | B7KO | CD28KO | ||
Thymus | NK1.1−CD4+ | 0.05±0.02 | 0.06±0.01 | 0.06±0.01 |
NK1.1+CD4+ | 0.52±0.23 | 0.13±0.02* | 0.03±0.01* | |
NK1.1+CD4− | 0.3±0.15 | 0.03±0.01* | 0.03±0.01* | |
Spleen | NK1.1−CD4+ | 0.21±0.04 | 0.22±0.05 | 0.16±0.03 |
NK1.1+CD4+ | 0.53±0.07 | 0.23±0.06** | 0.13±0.05*** | |
NK1.1+CD4− | 0.1±0.01 | 0.03±0.01*** | 0.02±0.01*** | |
Liver | NK1.1−CD4+ | 0.48±0.26 | 1.21±0.29* | 0.68±0.21 |
NK1.1+CD4+ | 1.34±0.44 | 1.46±0.33 | 0.64±0.19* | |
NK1.1+CD4− | 0.72±0.26 | 0.3±0.05* | 0.21±0.05* |
Lymphocytes from thymus, spleen and liver of age and sex-matched WT, B7-1(-/-)/B7-2(-/-) or CD28(-/-) mice were analyzed by flow cytometry. The iVα14 NKT cells were identified based on expressing TCRβ and binding to the α-Galcer/CD1d tetramer. Data shown are means and SD of the percentage of given subsets in total viable lymphocytes (n = 4). Similar data were obtained in another experiment involving 5 mice per group.
P<0.05,
P<0.01,
P<0.001.